Dimensional Fund Advisors’s Standard BioTools LAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-97,175
| Closed | -$105K | – | 3304 |
|
|
2025
Q1 | $105K | Sell |
97,175
-161,722
| -62% | -$227K | ﹤0.01% | 3200 |
|
|
2024
Q4 | $453K | Sell |
258,897
-73,484
| -22% | -$137K | ﹤0.01% | 3056 |
|
|
2024
Q3 | $641K | Sell |
332,381
-30,004
| -8% | -$58.8K | ﹤0.01% | 2994 |
|
|
2024
Q2 | $641K | Sell |
362,385
-904,474
| -71% | -$2.21M | ﹤0.01% | 2988 |
|
|
2024
Q1 | $3.43M | Buy |
+1,266,859
| New | +$3.06M | ﹤0.01% | 2645 |
|
|
2023
Q4 | – | Sell |
-54,398
| Closed | -$158K | – | 3437 |
|
|
2023
Q3 | $158K | Hold |
54,398
| – | – | ﹤0.01% | 3252 |
|
|
2023
Q2 | $105K | Sell |
54,398
-28,215
| -34% | -$55.7K | ﹤0.01% | 3316 |
|
|
2023
Q1 | $161K | Sell |
82,613
-68,367
| -45% | -$135K | ﹤0.01% | 3241 |
|
|
2022
Q4 | $176 | Sell |
150,980
-238,348
| -61% | -$293K | ﹤0.01% | 3248 |
|
|
2022
Q3 | $429K | Sell |
389,328
-568,519
| -59% | -$860K | ﹤0.01% | 3074 |
|
|
2022
Q2 | $1.53M | Sell |
957,847
-12,723
| -1% | -$31.5K | ﹤0.01% | 2820 |
|
|
2022
Q1 | $3.48M | Sell |
970,570
-75,943
| -7% | -$262K | ﹤0.01% | 2647 |
|
|
2021
Q4 | $4.1M | Buy |
1,046,513
+94,656
| +10% | +$443K | ﹤0.01% | 2628 |
|
|
2021
Q3 | $6.27M | Buy |
951,857
+199,572
| +27% | +$1.31M | ﹤0.01% | 2517 |
|
|
2021
Q2 | $4.63M | Buy |
752,285
+33,310
| +5% | +$178K | ﹤0.01% | 2635 |
|
|
2021
Q1 | $3.25M | Buy |
718,975
+66,776
| +10% | +$367K | ﹤0.01% | 2712 |
|
|
2020
Q4 | $3.91M | Buy |
652,199
+126,111
| +24% | +$829K | ﹤0.01% | 2606 |
|
|
2020
Q3 | $3.91M | Buy |
526,088
+90,572
| +21% | +$625K | ﹤0.01% | 2527 |
|
|
2020
Q2 | $1.75M | Buy |
435,516
+112,245
| +35% | +$391K | ﹤0.01% | 2801 |
|
|
2020
Q1 | $821K | Buy |
323,271
+72,756
| +29% | +$239K | ﹤0.01% | 2956 |
|
|
2019
Q4 | $872K | Buy |
250,515
+109,887
| +78% | +$387K | ﹤0.01% | 3033 |
|
|
2019
Q3 | $651K | Buy |
+140,628
| New | +$1.11M | ﹤0.01% | 3099 |
|
|
2017
Q4 | – | Sell |
-106,810
| Closed | -$538K | – | 3330 |
|
|
2017
Q3 | $538K | Sell |
106,810
-29,193
| -21% | -$123K | ﹤0.01% | 3095 |
|
|
2017
Q2 | $549K | Buy |
136,003
+11,557
| +9% | +$54.8K | ﹤0.01% | 3076 |
|
|
2017
Q1 | $708K | Hold |
124,446
| – | – | ﹤0.01% | 3036 |
|
|
2016
Q4 | $906K | Sell |
124,446
-10,425
| -8% | -$65.5K | ﹤0.01% | 2990 |
|
|
2016
Q3 | $1.08M | Hold |
134,871
| – | – | ﹤0.01% | 2919 |
|
|
2016
Q2 | $1.22M | Buy |
134,871
+118,816
| +740% | +$1.12M | ﹤0.01% | 2878 |
|
|
2016
Q1 | $130K | Hold |
16,055
| – | – | ﹤0.01% | 3219 |
|
|
2015
Q4 | $174K | Hold |
16,055
| – | – | ﹤0.01% | 3229 |
|
|
2015
Q3 | $130K | Buy |
+16,055
| New | +$253K | ﹤0.01% | 3284 |
|
Other funds holding LAB
CC
LFCM
NAMA
Dimensional Fund Advisors's LAB Position: Q2 2025 in Review
Dimensional Fund Advisors sold out of Standard BioTools (LAB) in Q2 2025, closing a stake of 97,175 shares — an estimated $105K sold.
Dimensional Fund Advisors first reported a position in LAB in Q3 2015 and held it in 31 quarters. The position peaked at $6.27M in Q3 2021. 160 funds tracked by Wall St. Rank hold LAB as of Q2 2025.
- Dimensional Fund Advisors reported no remaining Standard BioTools position as of Q2 2025 after selling out during the quarter.
- Dimensional Fund Advisors sold 97,175 Standard BioTools shares in Q2 2025, an estimated $105K.
- Dimensional Fund Advisors first reported a position in Standard BioTools in Q3 2015 and held it in 31 quarters.
- Dimensional Fund Advisors's Standard BioTools position peaked at $6.27M in Q3 2021.
- 160 funds tracked by Wall St. Rank held Standard BioTools as of Q2 2025.
Based on Dimensional Fund Advisors's 13F filing for Q2 2025, filed 12 Aug 2025.